|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 344 JPY | -1.43% |
|
+14.67% | -44.34% |
Perseus Proteomics Inc. provided earnings guidance for the fiscal year ending March 31, 2024. For the year, the company expects net sales to be JPY 100 million. Operating loss to be JPY 991 million.
Loss to be JPY 1,185 million. Basic loss per share to be JPY 100.84.
| 1st Jan change | Capi. | |
|---|---|---|
| -44.34% | 26.72M | |
| -4.06% | 86.13B | |
| +1.97% | 39.82B | |
| +56.59% | 25.23B | |
| -13.57% | 15.36B | |
| -8.82% | 11.95B | |
| -15.54% | 11.6B | |
| -41.58% | 11.51B | |
| +6.14% | 8.71B | |
| -7.02% | 8.12B |
PERSEUS PROTEOMICS INC. 
